Similarly, simvastatin, a clinically used cholesterol-lowering agent, inhibits IL-17 but enhances IL-10 to reverse Th17/Treg imbalance in COPD patients [77]. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.